These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Heart transplant coronary artery disease in Chinese recipients. Lee KC, Chang CY, Chuang YC, Young MS, Huang CM, Yin WH, Tung DY, Lee WC, Lee SL, Sue SH, Wei J. Transplant Proc; 2004 Oct; 36(8):2380-3. PubMed ID: 15561255 [Abstract] [Full Text] [Related]
3. Outcomes in patients older than 60 years of age undergoing orthotopic heart transplantation: an analysis of the UNOS database. Weiss ES, Nwakanma LU, Patel ND, Yuh DD. J Heart Lung Transplant; 2008 Feb; 27(2):184-91. PubMed ID: 18267225 [Abstract] [Full Text] [Related]
4. Is bridging to transplantation with a left ventricular assist device a risk factor for transplant coronary artery disease? Radovancevic B, Golino A, Vrtovec B, Thomas CD, Radovancevic R, Odegaard P, van Rossem CC, Gaemers SJ, Vaughn WK, Smart FW, Frazier OH. J Heart Lung Transplant; 2005 Jun; 24(6):703-7. PubMed ID: 15949730 [Abstract] [Full Text] [Related]
5. Factors associated with long-term survival following cardiac transplantation. Sareyyüpoğlu B, Kirali K, Göksedef D, Rabuş MB, Tuncer A, Erentuğ V, Mansuroğlu D, Yakut C. Anadolu Kardiyol Derg; 2008 Oct; 8(5):360-6. PubMed ID: 18849228 [Abstract] [Full Text] [Related]
6. [Heart transplantation 1985-1995: 10 years experience at the "Angelo De Gasperis" center. Improvement of results by progress in operative criteria]. Colombo T, Borrello B, Lanfranconi M, Pomé G, Quaini E, Russo C, Vitali E, Grassi M, Frigerio M, Gronda E, Mangiavacchi M, Merli M, Pellegrini A. G Ital Cardiol; 1997 Jan; 27(1):3-18. PubMed ID: 9244710 [Abstract] [Full Text] [Related]
7. Outcome after pediatric heart transplantation: two decades of a single center experience. Gambino A, Cerutti A, Feltrin G, Toscano G, Tarantini G, Milanesi O, Angelini A, Gerosa G. Eur J Cardiothorac Surg; 2007 Aug; 32(2):220-4. PubMed ID: 17590347 [Abstract] [Full Text] [Related]
12. Morbidity, functional status, and immunosuppressive therapy after heart transplantation: an analysis of the joint International Society for Heart and Lung Transplantation/United Network for Organ Sharing Thoracic Registry. Brann WM, Bennett LE, Keck BM, Hosenpud JD. J Heart Lung Transplant; 1998 Apr; 17(4):374-82. PubMed ID: 9588582 [Abstract] [Full Text] [Related]
15. Freedom from graft vessel disease in heart and combined heart- and kidney-transplanted patients treated with tacrolimus-based immunosuppression. Groetzner J, Kaczmarek I, Mueller M, Huber S, Deutsch A, Daebritz S, Arbogast H, Meiser B, Reichart B. J Heart Lung Transplant; 2005 Nov; 24(11):1787-92. PubMed ID: 16297783 [Abstract] [Full Text] [Related]
16. Negative pretransplant serostatus for Toxoplasma gondii is associated with impaired survival after heart transplantation. Doesch AO, Ammon K, Konstandin M, Celik S, Kristen A, Frankenstein L, Müller S, Sack FU, Katus HA, Dengler TJ. Transpl Int; 2010 Apr 01; 23(4):382-9. PubMed ID: 19912587 [Abstract] [Full Text] [Related]
17. Heart transplantation in females: the experience in Puerto Rico. Banchs HL, González V, González Cancel I, Quintana C, Calderón R, Altieri PI. Bol Asoc Med P R; 2005 Apr 01; 97(4):248-56. PubMed ID: 16599066 [Abstract] [Full Text] [Related]
18. Lung transplantation for cystic fibrosis: 6-year follow-up. Quattrucci S, Rolla M, Cimino G, Bertasi S, Cingolani S, Scalercio F, Venuta F, Midulla F. J Cyst Fibros; 2005 May 01; 4(2):107-14. PubMed ID: 15914093 [Abstract] [Full Text] [Related]
20. Ischaemic heart disease is a risk factor for renal failure after heart transplantation. Hosková L, Viklický O, Málek I, Podzimková M, Hegarová M, Pirk J, Vítko S, Kautzner J. Int J Cardiol; 2008 Jan 24; 123(3):358-60. PubMed ID: 17360057 [Abstract] [Full Text] [Related] Page: [Next] [New Search]